Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks

ConditionSleep Apnea
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-85
SponsorUniversity of Miami

About this trial

The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).

Eligibility criteria

Qualifiers

Self-reported race/ethnicity as African American, African, Caribbean or black

Ages 60-85 years

accessible by phone

OSA diagnosis

Disqualifiers

progressive illnesses in which disability or death is expected within 1 year

impaired cognitive/ functional ability precluding participation

intention to move within the year

and a family member currently enrolled.

Trial design

Treatments tested in this trial

  • Standard of Care
  • Personalized OSA Treatment

Treatment groups

330 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Miami

Lead sponsor

National Institute on Aging (NIA)

Collaborator